We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
How Magnetic Stimulation Affects the Brain
News

How Magnetic Stimulation Affects the Brain

How Magnetic Stimulation Affects the Brain
News

How Magnetic Stimulation Affects the Brain

Credit: Gerd Altmann/ Pixabay
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "How Magnetic Stimulation Affects the Brain"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

For the first time, researchers have shown what happens to the brain when a person receives a depression treatment known has repetitive transcranial magnetic stimulation (rTMS). The results were published today in the American Journal of Psychiatry.


rTMS is a depression treatment typically used when other approaches — such as medications — haven’t been effective for a patient. It is estimated that approximately 40 per cent of people with major depression do not respond to antidepressants.


During an rTMS session, a device containing an electromagnetic coil is placed against a patient’s scalp. The device then painlessly delivers a magnetic pulse that stimulates nerve cells in a region of the brain involved in mood control — called the dorsolateral pre-frontal cortex.


Although proven to be effective, the mechanisms behind how rTMS affects the brain have not been well understood.


“When we first started this research, the question we were asking was very simple: we wanted to know what happens to the brain when rTMS treatment is being delivered,” says Dr. Fidel Vila-Rodriguez, an assistant professor in UBC’s department of psychiatry and researcher at the Djavad Mowafaghian Centre for Brain Health (DMCBH).


To answer this question, Dr. Vila-Rodriguez and his team delivered one round of rTMS to patients while they were inside a magnetic resonance imaging (MRI) scanner. Since the MRI can measure brain activity, the researchers were able to see in real time what changes were happening in the brain.


The team found that by stimulating the dorsolateral pre-frontal cortex, several other regions of the brain were also activated. These other regions are involved in multiple functions — from managing emotional responses to memory and motor control.

“We wanted to know what happens to the brain when rTMS treatment is being delivered.”
Dr. Fidel Vila-Rodriguez

The participants then underwent another four weeks of rTMS treatment and the team assessed whether the activated regions were associated with patients having fewer symptoms of depression when their treatment ended.


“We found that regions of the brain that were activated during the concurrent rTMS-fMRI were significantly related to good outcomes,” says Dr. Vila-Rodriguez.


With this new map of how rTMS stimulates different areas of the brain, Dr. Villa-Rodriguez hopes the findings could be used to determine how well a patient is responding to rTMS treatments.


“By demonstrating this principle and identifying regions of the brain that are activated by rTMS, we can now try to understand whether this pattern can be used as a biomarker,” he says.


Dr. Vila-Rodriguez is now exploring how rTMS can be used to treat a range of neuropsychiatric disorders. He has received funding through the Djavad Mowafaghian Centre for Brain Health Alzheimer’s Disease Research Competition to look at rTMS as a way to enhance memory in patients who are showing early signs of Alzheimer’s disease. He also received a grant from the Canadian Institutes of Health Research (CIHR) to study whether the rTMS brain activation patterns can be detected by changes in heart rate.


Dr. Vila-Rodriguez says this type of research will hopefully encourage more widespread adoption and accessibility of rTMS treatments across the country. Despite being approved by Health Canada 20 years ago, rTMS is still not widely available. In British Columbia, there are some private clinics that offer rTMS, but it is not covered by the provincial health plan.


This research was a collaborative effort across the Centre for Brain Health, including DMCBH researchers Dr. Sophia FrangouDr. Rebecca Todd, and Dr. Erin MacMillan, as well as members of the UBC MRI Research Centre including Laura Barlow.


Reference: Ge R, Humaira A, Gregory E, et al. Predictive value of acute neuroplastic response to RTMS in treatment outcome in depression: A concurrent TMS-fMRI trial. Am J Psychiatry. 2022:appi.ajp.21050541. doi: 10.1176/appi.ajp.21050541


This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.


Advertisement